Indufin completed the acquisition of 37% stake in Corfim.

Synopsis

Indufin, a private equity firm, completed the acquisition of 37% stake in Corfim, a provider of biochemical, biomedical, bioplastic, and food ingredient solutions. Financial terms were not disclosed.

Principals

target

Corfim

bidder

INDUFIN

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

Market Context